chr6-159683812-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000636.4(SOD2):c.523+1042C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.767 in 151,978 control chromosomes in the GnomAD database, including 45,131 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.77 ( 45131 hom., cov: 31)
Consequence
SOD2
NM_000636.4 intron
NM_000636.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.536
Publications
15 publications found
Genes affected
SOD2 (HGNC:11180): (superoxide dismutase 2) This gene is a member of the iron/manganese superoxide dismutase family. It encodes a mitochondrial protein that forms a homotetramer and binds one manganese ion per subunit. This protein binds to the superoxide byproducts of oxidative phosphorylation and converts them to hydrogen peroxide and diatomic oxygen. Mutations in this gene have been associated with idiopathic cardiomyopathy (IDC), premature aging, sporadic motor neuron disease, and cancer. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 1. [provided by RefSeq, Apr 2016]
SOD2 Gene-Disease associations (from GenCC):
- cardiomyopathyInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.831 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SOD2 | NM_000636.4 | c.523+1042C>A | intron_variant | Intron 4 of 4 | ENST00000538183.7 | NP_000627.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.767 AC: 116454AN: 151860Hom.: 45102 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
116454
AN:
151860
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.767 AC: 116529AN: 151978Hom.: 45131 Cov.: 31 AF XY: 0.768 AC XY: 57044AN XY: 74244 show subpopulations
GnomAD4 genome
AF:
AC:
116529
AN:
151978
Hom.:
Cov.:
31
AF XY:
AC XY:
57044
AN XY:
74244
show subpopulations
African (AFR)
AF:
AC:
28989
AN:
41428
American (AMR)
AF:
AC:
12670
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
2631
AN:
3472
East Asian (EAS)
AF:
AC:
2756
AN:
5138
South Asian (SAS)
AF:
AC:
4113
AN:
4826
European-Finnish (FIN)
AF:
AC:
8827
AN:
10558
Middle Eastern (MID)
AF:
AC:
233
AN:
294
European-Non Finnish (NFE)
AF:
AC:
54104
AN:
67976
Other (OTH)
AF:
AC:
1632
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1345
2690
4035
5380
6725
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
860
1720
2580
3440
4300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2388
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.